Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons
- 31 August 2008
- journal article
- review article
- Published by Elsevier BV in Pharmacology Biochemistry and Behavior
- Vol. 90 (2), 198-207
- https://doi.org/10.1016/j.pbb.2007.10.003
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) administration in awake ratsNeurochemistry International, 2007
- Causes and consequences of methamphetamine and MDMA toxicityThe AAPS Journal, 2006
- Evidence for the Preferential Involvement of 5-HT2A Serotonin Receptors in Stress- and Drug-Induced Dopamine Release in the Rat Medial Prefrontal CortexNeuropsychopharmacology, 2005
- A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulantsBrain Research Reviews, 1997
- Carrier‐dependent and Ca2+‐dependent 5‐HT and dopamine release induced by (+)‐amphetamine, 3,4‐methylendioxy‐methamphetamine, p‐chloroamphetamine and (+)‐fenfluramineBritish Journal of Pharmacology, 1997
- MDMA induced dopamine release in vivo: role of endogenous serotoninJournal of Neural Transmission, 1997
- Reinforcing effects of certain serotonin-releasing amphetamine derivativesPharmacology Biochemistry and Behavior, 1996
- Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicityPharmacology Biochemistry and Behavior, 1993
- Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudatePharmacology Biochemistry and Behavior, 1991
- Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by microdialysisLife Sciences, 1990